Literature DB >> 1590187

Facial trauma and 3-D reconstructive imaging: insufficiencies and correctives.

R A Levy1, W T Edwards, J R Meyer, A E Rosenbaum.   

Abstract

PURPOSE: To address the clinical relevance of and optimal technique for 3-D CT imaging of facial trauma.
METHODS: Bioengineered cadaveric models were developed to enhance the concepts of LeFort. Diverse CT imaging techniques were applied to obtain optimal data sets for processing on various 3-D workstations. The fidelity of the 3-D reconstructions was determined by comparison with photographs of the cadaveric models. Optimized 3-D images were then used in conjunction with the initial 2-D data sets to assess whether additional accuracy was contributed by the 3-D images in the evaluation of modeled facial fractures.
RESULTS: Image definition was heavily dependent upon the specific 3-D reconstruction algorithm and the processor utilized. Orbital fractures were best imaged when 1- to 1.5-mm coronal sections were processed on an advanced 3-D workstation. The 3-D CT images resulted in additional accuracy in the 2-D CT evaluation of facial fractures in 29% of trials.
CONCLUSIONS: We believe that bioengineered models of facial trauma--matched with appropriate CT scanning parameters--facilitate graphically reliable 3-D reconstructive imaging. 3-D reconstructions can improve accuracy in the 2-D CT evaluation of facial trauma.

Entities:  

Mesh:

Year:  1992        PMID: 1590187      PMCID: PMC8331689     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  2 in total

Review 1.  Radiologic assessment of maxillofacial, mandibular, and skull base trauma.

Authors:  Bernhard Schuknecht; Klaus Graetz
Journal:  Eur Radiol       Date:  2005-01-21       Impact factor: 5.315

2.  Three-dimensional computed tomography imaging in the evaluation of craniofacial abnormalities.

Authors:  C F Darling; S E Byrd; E D Allen; M A Radkowski; M A Wilczynski
Journal:  J Natl Med Assoc       Date:  1994-09       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.